Golden Goose IPO "PPD" This IPO was just listed on FEB, 6th 2020 and will be killing it every earnings and has the potential to big a really big play in the market during these times. The chart I have posted is a 4HR time frame. Definitely one to add to your portfolio for awhile! I can see this being a GOLDEN GOOSE to get into early during these times! options plays are good on this one as well to play.
Pivot points and resistance are $26.86 / $28 / $29.37 on the 4HR time frame. The Linear reg. channel is bullish on all time frames up to the 3 min. when it becomes semi neutral.
Listed at 100% buy right now on Robinhood
NASDAQ:PPD Inc. provides drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The firm also provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations and other industry participants. Its clinical development services include all phases of development (Phase I-IV), peri- and post-approval and site and patient access services; laboratory services offers advanced testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.
Biopharmaceuticals
Alexion: Trading around Volume Profile POCIf you like this idea, don't forget to hit the Like Button!
Alexion business depends on patent-protected therapies in ultrarare and rare diseases of high unmet medical needs. While competitors are entering the market with biosimilars, Alexion still maintains an essential share of the market. My long term view is bullish.
However, from a technical point of view, we are in a critical consolidation phase that started at the end of October 2019. The stock price is consolidating around $107.88 level.
What to do now?
I would wait for Alexion to exit the consolidation phase with a breakout. My signal is the break of the $116.61 important resistance. Look at the purple line in the graph (Developing POC) to monitor interesting volumes movements able to push up the price (in the chart Developing POC is overlapping the POC red line). I suggest to not go in with a trade immediately after the resistance breakout since Alexion presents high uncertainty. Thus wait for a confirmation green candle (daily).
Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties.
Before buying or selling any stock you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.
I am not a financial advisor.
Imminent break to the upside for Clovis Oncology.I think we will see a sharp move this month. From reading the chart alone I am wagering it's going to be a bullish move... even though the fundamentals of the company are up for debate.
BMRN ridiculous Morningstar analyst target price! Morningstar weekly highlights set Biomarin Pharmaceuticals with an amazing $119 fair price value ( 50% above current price).
Rating: 4 stars
Uncertainty rating: Medium
Moat: Narrow
TRVN: Trend PlayThis stock popped up on my stock screener the other day.
I wanted to document this trade in case it ends up going well.
What I'm seeing here on the daily is a break above it's 100 then 200 MA. Now we are in this consolidation period with a little coiling action happening within the triangle I've drawn.
It's clear price is going to break in an explosive way whether that's up or down.
I have a stop limit placed at $1.68 for a break out to the upside.
I will move my stop loss up as price advances to lock in gains.
Check out Assetguild.com for more detailed analysis and blog content.
ABBV consolidating with gap to fill higherWatching for ABBV to break this wedge and go higher to fill the gap from earnings.
Risk takers: AXSM: Again looks promising to me. Warning: High risk pharmaceutical company. I was early in my last chart in January.
Chart looks more promising to me now. The company is developing non opioid treatments for joint pain, depression, and Alzheimer's disease. Pipeline (see ling below) is in clinical trials. If trials fail often get large drops in price and vice versa. With the opioid crisis IF these meds are helpful would be great potential. Watch for breakup above "1". Have a great weekend.
axsome.com
recent news: seekingalpha.com
BLRX - BREAKOUT - UPDATEBLRX is about to breakout.
6HR Chart
Daily:
Elliot Waves:
Breakout should be imminent...
Celgene ($celg) if tomorrow...if only tomorrow....Weekly chart: we have the downtrend channel clearly defined on a weekly basis. On a monthly basis we have already had a minimum of swing with a dragon fly bullish, on a daily chart some signs of an incoming uptrend as described in the latest posts...but tomorrow...tomorrow is where we play the game with the last resistence in place at 86.72 dollars. Once we get out of the channel and we leave this solid resistance it will mean that Celgene will be ready to come back to war.
I will be long in case the price breaks such thresold because signs of long will get really clear.
$RDGL Vivos looking STRONGSee previous for more detail -- just wanted a fresh chart w/ updated targets and a shorter interval.
Biogen Earnings Swing July 2018Biogen's (344.10 at close at the date of this writing) and Eisai's recent success with BAN24O1, an experimental medication for Alzheimer's which is currently in mid-stage clinical trials, in addition to a recent price target raise by Citi, and overall bullish analyst sentiment led to a rally between July 6-9, 2018.
Although the clinical trial's success was certainly reason for bullish sentiment, it ran too far too fast and indicators pointed towards to a sell off. I thus opened put options on July 9, expiring July 13 2018 (currently in the money). We are now only about two weeks away from Biogen's earning report. After studying historical data and charts, I've found that there is often a sell off prior to earnings OR there is a run up then a slight sell off right before the earnings date. I've annotated the chart with periods that indicate this.
In this case, I believe downward momentum will continue followed by a slight rally pre-earnings then a sell off. Opening JUL20 puts may be a smart move at this time.
In the long term, Biogen -0.21% is very scalable and overall is very promising. I agree with Citi's PT of 371.
www.wsj.com
KTOV FDA Approval take gains and get out As expected KTOV passed the FDA approval time to take some gains and move on to the next one.
finance.yahoo.com
KTOV dump before 31st PDUFA date
NASDAQ:KTOV PDUFA date as seen on this calander www.biopharmcatalyst.com I believe the stock is dumping prior to a pump following positive news of a drug appoval.
Evening Doji Star possible for tomorrow #AKERWe have conflicting signals here, as the RVI is near the sweet spot, the VI (-) is coming up again, VI (+) is stagnating, and the volume hasn't had more than 3 consecutive days of positive momentum for weeks.
Why I won't sell MNKD yetI spy, with my little eye, an inverted head and shoulders. Plus a ER surprise.
tkai long risk/reward 1.64Tkai massive upside potential. In other words, buy between .99 and current price 1.06 and aim to get out in the 1.2's. Current price is the high point of first wave up (the XA)..price descended appropriately (1--> .618) for support, and moved higher between the 1.21 and 1.41 exetension of XA. The following downtrend in price should suggest a move upwards to at LEAST 1.2s.
Why MSTX may not rise until at least 10/3With Section 8 Rules, I don't expect the shares to fall much lower than they already have. But, with Fib Time Trend, it looks like shares may not rise until at least Oct 3, maybe early next week? But with the possibility of being removed if shares fall to 6, I can't imagine them falling much more than another penny or so to around 9 before taking off. What say ye?
Sophiris (SPHS) Multi-month Ascending Broadening Wedge - BullishSPHS is in a multi-year ABW and with the latest partial decline, in addition to other important fundamental and technical factors, it will likely breakout upwards - To infinity and beyond!!
Entered Long Position Completion of reverse split saw consolidation about 1.90 and looking like its going to jump to 2+. Going to buy on any dips below 1.9 to lower cost basis. 6 month PT @ 3.00+.
